2009
DOI: 10.1007/s00213-009-1666-5
|View full text |Cite
|
Sign up to set email alerts
|

Bupropion and nicotine enhance responding for nondrug reinforcers via dissociable pharmacological mechanisms in rats

Abstract: Rationale-Nicotine serves as a primary reinforcer but also potently enhances responding for nonnicotine stimuli with reinforcing properties. One of the most successful pharmacotherapies for smoking cessation, bupropion, also increases responding for non-drug reinforcers such as food and brain stimulation rewards.Objective-The present studies investigated whether treatment with bupropion and nicotine had similar effects on responding for a reinforcing visual stimulus (VS). They also investigated whether the eff… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
20
1

Year Published

2011
2011
2023
2023

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations
Cited by 32 publications
(24 citation statements)
references
References 69 publications
3
20
1
Order By: Relevance
“…In addition, other stimulants or similar drugs may comparably enhance reinforcement from non-drug rewards (e.g. Palmatier, Levin, Mays, Donny, Caggiula, & Sved, 2009; Sheppard, Gross, Pavelka, Hall, & Palmatier, 2012), including sensory types (Lloyd et al, 2012; Perkins et al 2013). …”
Section: Discussionmentioning
confidence: 99%
“…In addition, other stimulants or similar drugs may comparably enhance reinforcement from non-drug rewards (e.g. Palmatier, Levin, Mays, Donny, Caggiula, & Sved, 2009; Sheppard, Gross, Pavelka, Hall, & Palmatier, 2012), including sensory types (Lloyd et al, 2012; Perkins et al 2013). …”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, both bupropion (Caggiula et al, 2009) and varenicline (Levin et al, 2012), both FDA-approved prescription pharmacotherapies for the treatment of smoking cessation, can substitute for the reinforcement-enhancing effects of nicotine, which may partially underlie their efficacy as pharmacotherapies. To test the ability of buproprion to enhance the reinforcing valence of VS presentations, nicotine or bupropion was systemically administered across sessions (Palmatier et al, 2009). Both nicotine and bupropion increased responding for VS presentations.…”
Section: 0 Reinforcement-enhancing Effects Of Nicotinementioning
confidence: 99%
“…Intriguingly, responding for a rewarding visual stimulus is enhanced by bupropion in a manner similar to that of nicotine (e.g. Palmatier et al, 2009), consistent with other preclinical research on bupropion (Paterson, Balfour, & Markou, 2008). We know of no prior research in humans examining the effects of cessation medications, including bupropion, on enhancement of reinforced responding, although nicotine lozenge may enhance card-sorting performance after Advance Access publication October 24, 2012 nicotine & tobacco research, Volume 15, number 6 (June 2013) 1141-1145 overnight abstinence in heavier (>15/day) but not lighter smokers (Dawkins et al, 2006).…”
Section: Introductionmentioning
confidence: 99%